| 今开：0.0 | 昨收：39.95 |
| 最高：0.0 | 最低：0.0 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：5.512175197E9 |
日本安斯泰来制药公司（Astellas Pharma）周一表示，将通过安斯泰来美国控股公司的全资子公司Berry Merger Sub收购纳斯达克上市的IVERIC Bio Inc．的全部在外流通股份。 IVERIC Bio是一家生物制药公司，致力于研发视网膜... 网页链接
$IVERIC bio(ISEE)$ 15-12G Securities registration termination [Section 12(g)] Accession Number: 0001104659-23-082897 Act: 34 Size: 11 KB 网页链接
$IVERIC bio(ISEE)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-002103 Act: 33 Size: 1 KB 网页链接
$IVERIC bio(ISEE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-080680 Size: 18 KB 网页链接
$IVERIC bio(ISEE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-080684 Size: 28 KB 网页链接
$IVERIC bio(ISEE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-080683 Size: 21 KB 网页链接
$IVERIC bio(ISEE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-080679 Size: 21 KB 网页链接
$IVERIC bio(ISEE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-080685 Size: 19 KB 网页链接
$IVERIC bio(ISEE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-080682 Size: 32 KB 网页链接
$IVERIC bio(ISEE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-080690 Size: 15 KB 网页链接
$IVERIC bio(ISEE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-080692 Size: 17 KB 网页链接